Recruitment drive for next stages of human trials for Covid-19 vaccine

Andrew Cummings
May 26, 2020

Oxford University announced that its COVID-19 vaccine has entered its next phases of human trials, according to a statement on Friday, as British health authorities announced that 351 more people died from the disease across the United Kingdom over the past 24 hours. As there is now no vaccine available for coronavirus, but researchers and medicine makers are working on it.It could take a minimum of 18 months to develop. He, however, raised caution saying that people's expectations about the vaccine have to be managed as it isn't till the third phase of the trial that the vaccine's efficacy and safety can be gauged.

On Monday, the US-based firm Moderna tentatively said that all 45 people given its trial vaccine had created immune responses that could help protect them from the coronavirus.

The Oxford Vaccine Group is one of a few elite laboratories and facilities leading the race to find a vaccine.

Earlier, drugmaker AstraZeneca finalised its licence agreement with Oxford University for the recombinant adenovirus vaccine.


Will we really have a coronavirus vaccine in 12 to 18 months? . Still, the company said that it was committed to advancing the clinical program to the best of its abilities. It was supposed to produce 60 million doses of the vaccine within a year of getting the approval.

The first phase of the nationwide trial in adult volunteers began in Oxford in April. The company's President Dr. Stephen Hoge told "CBS This Morning" earlier this week it is proceeding to a Phase 2 trial, with Phase 3 expected to begin by early summer.

Despite certain apprehensions, the countries across the globe are rushing their vaccine projects, and some including China and the USA have even announced a tentative date.

It has redirected a £300,000 government grant - originally earmarked for work on a Zika vaccine - to its COVID-19 endeavour, but has applied for another £5 million in state support.


The wave of announcements about trials and initial results has stoked optimism about a potential vaccine for COVID-19, as the number of cases and deaths worldwide climbs.

"If transmission remains high, we may get enough data in a couple of months to see if the vaccine works, but if transmission levels drop, this could take up to six months", the university said in a statement.

But he added: "What is more hard to predict is how long it will take to get there and how well the vaccine (s) will work".


Other reports by iNewsToday

FOLLOW OUR NEWSPAPER